Ambu A/S

Copenhagen Stock Exchange AMBU-B.CO

Ambu A/S Price to Sales Ratio (P/S) on January 14, 2025: 6.20

Ambu A/S Price to Sales Ratio (P/S) is 6.20 on January 14, 2025, a -7.34% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Ambu A/S 52-week high Price to Sales Ratio (P/S) is 9.05 on August 29, 2024, which is 45.96% above the current Price to Sales Ratio (P/S).
Ambu A/S 52-week low Price to Sales Ratio (P/S) is 4.77 on January 02, 2025, which is -23.05% below the current Price to Sales Ratio (P/S).
Ambu A/S average Price to Sales Ratio (P/S) for the last 52 weeks is 6.82.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Copenhagen Stock Exchange: AMBU-B.CO

Ambu A/S

CEO	Ms. Britt Meelby Jensen
IPO Date	Feb. 11, 2004
Location	Denmark
Headquarters	Baltorpbakken 13
Employees	5,196
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Key trends

Past 5 years